These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34405874)

  • 41. Epicardial Ablation of Ventricular Tachycardia.
    Tung R; Shivkumar K
    Methodist Debakey Cardiovasc J; 2015; 11(2):129-34. PubMed ID: 26306131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation?
    Schmidt B; Chun KR; Baensch D; Antz M; Koektuerk B; Tilz RR; Metzner A; Ouyang F; Kuck KH
    Heart Rhythm; 2010 Dec; 7(12):1746-52. PubMed ID: 20709191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry.
    Tilz RR; Lin T; Eckardt L; Deneke T; Andresen D; Wieneke H; Brachmann J; Kääb S; Chun KRJ; Münkler P; Lewalter T; Hochadel M; Senges J; Kuck KH
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29572321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?
    Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A
    J Interv Card Electrophysiol; 2017 Mar; 48(2):193-199. PubMed ID: 27900527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices.
    Kusa S; Miller MA; Whang W; Enomoto Y; Panizo JG; Iwasawa J; Choudry S; Pinney S; Gomes A; Langan N; Koruth JS; d'Avila A; Reddy VY; Dukkipati SR
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28576780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease.
    Izquierdo M; Sánchez-Gómez JM; Ferrero de Loma-Osorio A; Martínez A; Bellver A; Peláez A; Núñez J; Núñez C; Chorro J; Ruiz-Granell R
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):882-9. PubMed ID: 26056239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and Feasibility of a Minimally Fluoroscopic Approach for Ventricular Tachycardia Ablation in Patients With Structural Heart Disease: Influence of the Ventricular Tachycardia Substrate.
    Cano Ó; Andrés A; Osca J; Alonso P; Sancho-Tello MJ; Olagüe J; Martínez-Dolz L
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003706. PubMed ID: 26850881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence, risk factors, and consequences of new-onset atrial fibrillation following epicardial ablation for ventricular tachycardia.
    Mahapatra S; LaPar DJ; Bhamidipati CM; McDaniel G; Kamath S; Bunch TJ; Ailawadi G
    Europace; 2011 Apr; 13(4):548-54. PubMed ID: 21296778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
    Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
    Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.
    Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG
    Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
    Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
    Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Romero J; Patel K; Briceno D; Alviz I; Gabr M; Diaz JC; Trivedi C; Mohanty S; Della Rocca D; Al-Ahmad A; Yang R; Rios S; Cerna L; Du X; Tarantino N; Zhang XD; Lakkireddy D; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2022-2031. PubMed ID: 32478430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonsurgical transthoracic epicardial radiofrequency ablation: an alternative in incessant ventricular tachycardia.
    Brugada J; Berruezo A; Cuesta A; Osca J; Chueca E; Fosch X; Wayar L; Mont L
    J Am Coll Cardiol; 2003 Jun; 41(11):2036-43. PubMed ID: 12798578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VT ablation in geriatric patients with structural heart disease: Should there still be an age limit?
    Darma A; Bertagnolli L; Dinov B; Torri F; Dagres N; Bollmann A; Hindricks G; Arya A
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):766-771. PubMed ID: 33428325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Outcome After Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Dilated Cardiomyopathy.
    Muser D; Santangeli P; Castro SA; Pathak RK; Liang JJ; Hayashi T; Magnani S; Garcia FC; Hutchinson MD; Supple GG; Frankel DS; Riley MP; Lin D; Schaller RD; Dixit S; Zado ES; Callans DJ; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience.
    Wei W; Liao H; Xue Y; Fang X; Huang J; Liu Y; Deng H; Liang Y; Liao Z; Liu F; Lin W; Zhan X; Wu S
    PLoS One; 2017; 12(1):e0169863. PubMed ID: 28122031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation.
    Berruezo A; Fernández-Armenta J; Andreu D; Penela D; Herczku C; Evertz R; Cipolletta L; Acosta J; Borràs R; Arbelo E; Tolosana JM; Brugada J; Mont L
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):326-36. PubMed ID: 25583983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracorporeal Membrane Oxygenation for Hemodynamic Support of Ventricular Tachycardia Ablation.
    Baratto F; Pappalardo F; Oloriz T; Bisceglia C; Vergara P; Silberbauer J; Albanese N; Cireddu M; D'Angelo G; Di Prima AL; Monaco F; Paglino G; Radinovic A; Regazzoli D; Silvetti S; Trevisi N; Zangrillo A; Della Bella P
    Circ Arrhythm Electrophysiol; 2016 Dec; 9(12):. PubMed ID: 27932426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review.
    Papageorgiou N; Providência R; Bronis K; Dechering DG; Srinivasan N; Eckardt L; Lambiase PD
    Europace; 2018 Apr; 20(4):682-691. PubMed ID: 28444174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.